ClinicalTrials.govpublic full text
Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer
advanced breast cancer, triple negative, olaparib, lynparza, brca, methylation, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 911502
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.